HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in Greater Kingston, Jamaica

West Indian Medical Journal

Volumn 53, Issue 5, 2004, Pages 297-302

  Johnson, N ^a,b,c,d   Mullings, A A ^a,b,c,d   Harvey, K M ^a,b,c,d   Alexander, G ^a,b,c,d   McDonald, D ^a,b,c,d   Smikle, M F ^a,b,c,d   Williams, E ^a,b,c,d   Palmer, P ^a,b,c,d   Whorms, S ^a,b,c,d   Figueroa, J P ^a,b,c,d   Christie, Celia D C ^a,b,c,d  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b Ministry of Health   (Jamaica)

^c Department of Paediatric Medicine   (Jamaica)

^d Victoria Jubilee Hospital   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CARIBBEAN ISLANDS; CHILDBIRTH; CLINICAL PROTOCOL; CONFIDENTIALITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; JAMAICA; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; NEWBORN; NEWBORN DEATH; PATIENT CARE; PATIENT COUNSELING; PATIENT REFERRAL; PREGNANCY; PRENATAL CARE; SEROLOGY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HUMANS; JAMAICA; NEVIRAPINE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL CARE; PROGRAM EVALUATION; ZIDOVUDINE;

EID: 10644264797     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), AIDS update: December 202. Geneva: UNAIDS/WHO, 2002. Avilable at http://www.who.int/hivpub/epidemiology/epi2002 /en.
2. Gomez MP, Bain RM, Major C, Gray H, Read SE, Characteristics of HIV-infected pregnant women in the Bahamas. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 400-5.
3. Dowe G, King SD, Smikle MF, Wynter HH, Chout R, Klaskala W. Prevalence of viral and bacterial sexually transmitted pathogens in Jamaican pregnant women. West Indian Med J 1998; 47: 23-5.
4. Perry D, Reid M, Thame M, Fletcher H, Mullings A, McCaw-Binns A et al. HIV infection seroprevalence and risk factor study among pregnant women attending the antenatal clinic at the University Hospital of the West Indies, Kingston, Jamaica. West Indian Med J 2002; 51: 80-3.
5. Wynter SH, Rattray C, Fredrick J, Thesiger C, Wynter HH, Lindo J. Who is at risk? A comparison of the seroprevalence of human immunodeficiency virus in pregnant women and a high risk group. West Indian Med J 2003; 52: 293-5.
6. Christie CDC. A Paediatric and Perinatal HIV/AIDS Leadership Initiative in Kingston, Jamaica. West Indian Med J 2004: 53: 283-92.
7. Rodriguez B, Steel-Duncan JC, Pierre R, Evans-Gilbert T, Hambleton I, Palmer P et al. Socio-demographic characteristics of HIV-exposed and HIV-infected Jamaican children. West Indian Med J 2004; 53: 303-7.
8. Steel-Duncan JC, Pierre R, Evans-Gilbert T, Rodriquez B, Smikle MF, Palmer P et al. Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica. West Indian Med J 2004; 53: 308-14.
9. Pierre R, Steel-Duncan JC, Evans-Gilbert T, Rodriguez B, Palmer P, Smikle MF, et al. CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS. West Indian Med J 2004; 53: 315-21.
10. Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriguez B, Whorms S, Hambleton IR et al. Antiretroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 2004; 53: 322-6.
11. Palmer P, Anderson-Allen MM, Billings CC, Moore JT, McDonald-Kerr C, Steel- Duncan JC et al. Nursing interventions in the Kingston Paediatric and Perinatal HIV/AIDS Programme. West Indian Med J 2004; 53: 327-31.
12. Connor EM, Sperling RS, Gerber R, Kiselev P, Scott G, O'Sullivan MJ et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine. Pediatric AIDS Clinical Trials Group. N Engl J Med 1994; 331: 1173-80.
13. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C et al. Combination antiretroviral strategies for treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-transmission. J Acqr Immun Defic Syndr 2002; 29: 484-94.
14. HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study. AIDS 2001; 15: 761-70.
15. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000; 343: 982-91.
16. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995; 142: 1330-7.
17. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for the prevention of mother to child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354: 795-802.
18. Harvey K, Figueroa JP, Tomlinson J, Gebre Y, Forbes S, Toyloy T et al. An assessment of mother-to-child HIV transmission prevention in 16 pilot antenatal clinics in Jamaica. West Indian Med J 2004; 53: 293-6.
19. Christie CD, Bain B, Pierre R, Smikle M, Evans-Gilbert T, Fredericks J et al. HIV/AIDS in women, infants, children and adolescents in Jamaica: a further call to action. West Indian Med J 2001; 50: 258-62.
20. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 1999; 340: 977-87.
21. Bulterys M, Chao A, Dushimimana A, Saah A. Fatal complications after Cesarean section in HIV-infected women. AIDS 1996; 10: 923-4.
22. Bassett MT. Keeping the M in MTCT: women, mothers and HIV prevention. Am J Public Health 2001; 91: 701-3.
23. Mitka M. MTCT-Plus program has two goals: end maternal transmission + treat mothers. JAMA 2002; 288: 153-4.
24. Mofenson L. A tale of two epidemics - the continuing challenge of preventing mother-to-child transmission of human immunodeficiency virus. J Infect Dis 2003; 187: 721-4.